Uterine leiomyosarcoma: A review of the literature and update on management options

ME Roberts, JT Aynardi, CS Chu - Gynecologic Oncology, 2018 - Elsevier
Uterine leiomyosarcoma is the most common type of uterine sarcoma. It is an extremely
aggressive malignancy associated with a poor overall prognosis. Women affected may vary …

Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications

S Pasquali, A Gronchi - Therapeutic advances in medical …, 2017 - journals.sagepub.com
Soft tissue sarcomas are a rare and multifaceted group of solid tumours. Neoadjuvant
chemotherapy is increasingly used to limit loss of function after wide surgical excision with …

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

PG Casali, N Abecassis, S Bauer, R Biagini… - Annals of …, 2018 - annalsofoncology.org
Soft tissue sarcomas (STSs) gather over 80 histological entities, with even more molecular
subsets, characterised by a low to very low incidence in all populations. The majority of …

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open …

A Gronchi, S Ferrari, V Quagliuolo, JM Broto… - The Lancet …, 2017 - thelancet.com
Background Previous trials from our group suggested an overall survival benefit with five
cycles of adjuvant full-dose epirubicin plus ifosfamide in localised high-risk soft-tissue …

Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961 …

RD Issels, LH Lindner, J Verweij, R Wessalowski… - JAMA …, 2018 - jamanetwork.com
Importance Patients with soft tissue sarcoma are at risk for local recurrence and distant
metastases despite optimal local treatment. Preoperative anthracycline plus ifosfamide …

[HTML][HTML] Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO/European Sarcoma Network Working Group - Annals of Oncology, 2014 - Elsevier
Extraskeletal Ewing sarcoma is covered by other ESMO Guidelines: in general, the same
principles for these tumours in children apply to adults. This is also the case for embryonal …

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: a Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

S Pasquali, E Palmerini, V Quagliuolo, J Martin‐Broto… - Cancer, 2022 - Wiley Online Library
Background The value of neoadjuvant chemotherapy in soft tissue sarcoma (STS) is not
completely understood. This study investigated the benefit of neoadjuvant chemotherapy …

[HTML][HTML] The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 …

S Pasquali, S Pizzamiglio, N Touati, S Litiere… - European journal of …, 2019 - Elsevier
Background This study was aimed at determining whether patients with high-risk soft tissue
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …

In vivo bioorthogonal chemistry enables local hydrogel and systemic pro-drug to treat soft tissue sarcoma

JM Mejia Oneto, I Khan, L Seebald… - ACS central science, 2016 - ACS Publications
The ability to activate drugs only at desired locations avoiding systemic immunosuppression
and other dose limiting toxicities is highly desirable. Here we present a new approach …

Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions

VDA Corino, E Montin, A Messina… - Journal of Magnetic …, 2018 - Wiley Online Library
Purpose To assess the feasibility of grading soft tissue sarcomas (STSs) using MRI features
(radiomics). Materials and Methods MRI (echo planar SE, 1.5 T) from 19 patients with STSs …